Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells
Küçük Resim Yok
Tarih
2024
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Mary Ann Liebert, Inc
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Chronic myeloid leukemia (CML) is a clonal myeloproliferative hematological disease characterized by the chimeric breakpoint-cluster region/Abelson kinase1 (BCR
Açıklama
Anahtar Kelimeler
Ponatinib, Combination Therapy, Cytokines, Stat5 Inhibitor Pimozide, Drug Resistance
Kaynak
Journal of Interferon and Cytokine Research
WoS Q Değeri
N/A
Scopus Q Değeri
Q2
Cilt
44
Sayı
4
